Inhibitors of calmodulin and protein kinase C block different phases of hippocampal long-term potentiation

Brain Res. 1988 Oct 4;461(2):388-92. doi: 10.1016/0006-8993(88)90274-0.

Abstract

The effects of a calmodulin (CaM) inhibitor, which does not influence Ca2+ fluxes (calmidazolium, RO-24571), and a new potent inhibitor of protein kinase C (K-252b) on long-term potentiation (LTP) were compared in hippocampal slices. Tetanic stimulation of the stratum radiatum during perfusion of calmidazolium (50 nM) failed to induce the characteristic post-tetanic and long-term increase in the magnitude of CA1-evoked responses. During perfusion with K-252b (50 nM) post-tetanic potentiation and initial LTP is expressed normally, but thereafter declines back to baseline with a 60 min delay. By themselves, the inhibitors had no significant effect on synaptic transmission in a non-tetanized control input. Our data are in line with current evidence from several laboratories that CaM- and protein kinase C (PKC)-dependent processes are involved in LTP and support the hypothesis that CaM mediates initiation and that PKC mediates mechanisms underlying the maintenance of LTP.

MeSH terms

  • Action Potentials / drug effects
  • Animals
  • Calmodulin / physiology*
  • Carbazoles / pharmacology*
  • Electric Stimulation
  • Enzyme Inhibitors / pharmacology*
  • Hippocampus / drug effects
  • Hippocampus / physiology*
  • Imidazoles / pharmacology*
  • In Vitro Techniques
  • Indole Alkaloids
  • Protein Kinase C / physiology*
  • Rats
  • Rats, Inbred Strains

Substances

  • Calmodulin
  • Carbazoles
  • Enzyme Inhibitors
  • Imidazoles
  • Indole Alkaloids
  • calmidazolium
  • staurosporine aglycone
  • Protein Kinase C